2012
DOI: 10.1016/j.canep.2012.02.007
|View full text |Cite
|
Sign up to set email alerts
|

The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality

Abstract: This paper presents the latest international descriptive epidemiological data for invasive breast cancer among women, including incidence, survival and mortality, as well as information on mammographic screening programs. Almost 1.4 million women were diagnosed with breast cancer worldwide in 2008 and approximately 459,000 deaths were recorded. Incidence rates were much higher in more developed countries compared to less developed countries (71.7/100,000 and 29.3/100,000 respectively, adjusted to the World 200… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

11
461
1
19

Year Published

2013
2013
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 637 publications
(492 citation statements)
references
References 92 publications
11
461
1
19
Order By: Relevance
“…Despite rapid advances in diagnosis and prognosis of breast cancer, it still remains the most common malignancy among women worldwide (Youlden et al, 2012). Several modifiable and non-modifiable risk factors have been associated with the incidence of breast cancer thereby providing compelling basis for development of breast cancer prevention and treatment strategies.…”
Section: Introductionmentioning
confidence: 99%
“…Despite rapid advances in diagnosis and prognosis of breast cancer, it still remains the most common malignancy among women worldwide (Youlden et al, 2012). Several modifiable and non-modifiable risk factors have been associated with the incidence of breast cancer thereby providing compelling basis for development of breast cancer prevention and treatment strategies.…”
Section: Introductionmentioning
confidence: 99%
“…Today it is the most prevalent cancer among women worldwide, both in developed and developing countries (GLOBOCAN, 2008). It is predicted that the incidence in 2050 will reach almost 3.2 million (Hortobagyi et al, 2005;McCormack and Boffetta, 2011;Youlden et al, 2012). The standardized incidence rates range from 19.3 per 100,000 women in Eastern Africa to 89.9 per 100,000 women in Western Europe.…”
Section: Introductionmentioning
confidence: 99%
“…BC is the most common cause of cancerrelated deaths among women worldwide. Each year it is newly diagnosed in more than 1.1 million of women worldwide (El-Zaemey, 2012;Youlden, 2012). In Iran, the proportion of BC incidence is about 10 percent of all cancers (Alimohammadian, 2009).…”
Section: Introductionmentioning
confidence: 99%